Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.87
SNWV's Cash to Debt is ranked lower than
67% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. SNWV: 0.87 )
SNWV' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.87

Equity to Asset -0.07
SNWV's Equity to Asset is ranked lower than
71% of the 447 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SNWV: -0.07 )
SNWV' s 10-Year Equity to Asset Range
Min: -23.67   Max: 0.21
Current: -0.07

-23.67
0.21
F-Score: 5
Z-Score: -24.52
M-Score: -2.50
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -696.89
SNWV's Operating margin (%) is ranked lower than
69% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. SNWV: -696.89 )
SNWV' s 10-Year Operating margin (%) Range
Min: -1621.98   Max: -747
Current: -696.89

-1621.98
-747
Net-margin (%) -714.00
SNWV's Net-margin (%) is ranked lower than
69% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. SNWV: -714.00 )
SNWV' s 10-Year Net-margin (%) Range
Min: -2049.73   Max: -832.38
Current: -714

-2049.73
-832.38
ROA (%) -127.51
SNWV's ROA (%) is ranked lower than
67% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. SNWV: -127.51 )
SNWV' s 10-Year ROA (%) Range
Min: -657.17   Max: -99.51
Current: -127.51

-657.17
-99.51
ROC (Joel Greenblatt) (%) -55017.54
SNWV's ROC (Joel Greenblatt) (%) is ranked lower than
67% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. SNWV: -55017.54 )
SNWV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -27528.13   Max: -4688.89
Current: -55017.54

-27528.13
-4688.89
Revenue Growth (%) -20.60
SNWV's Revenue Growth (%) is ranked lower than
93% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. SNWV: -20.60 )
SNWV' s 10-Year Revenue Growth (%) Range
Min: 0   Max: -12.6
Current: -20.6

EBITDA Growth (%) -27.20
SNWV's EBITDA Growth (%) is ranked lower than
101% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. SNWV: -27.20 )
SNWV' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: -24
Current: -27.2

EPS Growth (%) -28.50
SNWV's EPS Growth (%) is ranked lower than
107% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SNWV: -28.50 )
SNWV' s 10-Year EPS Growth (%) Range
Min: 0   Max: -20.4
Current: -28.5

» SNWV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with SNWV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 5.00
SNWV's P/S is ranked lower than
62% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. SNWV: 5.00 )
SNWV' s 10-Year P/S Range
Min: 3.25   Max: 111.25
Current: 5

3.25
111.25
EV-to-EBIT -0.52
SNWV's EV-to-EBIT is ranked lower than
62% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 64.69 vs. SNWV: -0.52 )
SNWV' s 10-Year EV-to-EBIT Range
Min: -8.2   Max: -0.2
Current: -0.52

-8.2
-0.2
Current Ratio 0.82
SNWV's Current Ratio is ranked lower than
68% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. SNWV: 0.82 )
SNWV' s 10-Year Current Ratio Range
Min: 0.04   Max: 6.9
Current: 0.82

0.04
6.9
Quick Ratio 0.78
SNWV's Quick Ratio is ranked lower than
68% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. SNWV: 0.78 )
SNWV' s 10-Year Quick Ratio Range
Min: 0.03   Max: 6.64
Current: 0.78

0.03
6.64

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.20
SNWV's Price/Median PS Value is ranked lower than
62% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. SNWV: 0.20 )
SNWV' s 10-Year Price/Median PS Value Range
Min: 0.16   Max: 4.17
Current: 0.2

0.16
4.17
Earnings Yield (Greenblatt) -192.30
SNWV's Earnings Yield (Greenblatt) is ranked lower than
68% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SNWV: -192.30 )
SNWV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -192.3

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
SANUWAVE Health Inc formerly known as Rub Music Enterprises, Inc., was incorporated in the State of Nevada on May 6, 2004. The Company is a shockwave technology company using a patented system of noninvasive, high-energy, acoustic shockwaves for regenerative medicine and other applications. Its regenerative product in the United States is the demaPACE device, used for treating diabetic foot ulcers subject to submission of satisfactory clinical study results. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The Company faces competition from medical device, biomedical technology and medical products and combination products companies, including major pharmaceutical companies. The Company's product candidates are subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act and/or the Public Health Service Act, as well as by other regulatory bodies.
» More Articles for SNWV

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
SANUWAVE Health Signs Memoranda of Understanding With Dasman Diabetes Institute and Kuwait Life... Dec 02 2014
SANUWAVE Enrolls 130th Patient in Its dermaPACE Clinical Trial Treating Diabetic Foot Ulcers Dec 01 2014
SANUWAVE HEALTH, INC. Financials Nov 22 2014
SNWV: Expect DMC Recommendation in Q1 Nov 17 2014
10-Q for SANUWAVE Health, Inc. Nov 14 2014
SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Nov 14 2014
SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update Nov 12 2014
SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report Nov 12 2014
SANUWAVE Health to Hold Third Quarter 2014 Financial Results Conference Call on Thursday, November... Nov 06 2014
Presentation Schedule Now Available for RedChip's October 15-16 Global Online CEO Conference Oct 06 2014
SNWV: DMC Recommendation Causes 4+ Month Delay Sep 10 2014
SNWV: DMC Evaluation Expected In September Aug 12 2014
SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Aug 08 2014
SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report Aug 06 2014
SANUWAVE HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 05 2014
SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... May 15 2014
SANUWAVE's (SNWV) Q1 2014 Results - Earnings Call Transcript May 14 2014
SNWV: We Remain Very Positive on Chances for Trial Success May 14 2014
SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report May 13 2014
SANUWAVE HEALTH, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in... Apr 21 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK